
Medexus Pharmaceuticals Inc
TSX:MDP

Intrinsic Value
The intrinsic value of one
MDP
stock under the Base Case scenario is
7.75
CAD.
Compared to the current market price of 2.69 CAD,
Medexus Pharmaceuticals Inc
is
Undervalued by 65%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Medexus Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Medexus Pharmaceuticals Inc
Balance Sheet Decomposition
Medexus Pharmaceuticals Inc
Current Assets | 66.7m |
Cash & Short-Term Investments | 8.4m |
Receivables | 14.1m |
Other Current Assets | 44.1m |
Non-Current Assets | 79.3m |
PP&E | 712k |
Intangibles | 69.3m |
Other Non-Current Assets | 9.3m |
Free Cash Flow Analysis
Medexus Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Medexus Pharmaceuticals Inc
Revenue
|
109.5m
USD
|
Cost of Revenue
|
-52.1m
USD
|
Gross Profit
|
57.5m
USD
|
Operating Expenses
|
-42.4m
USD
|
Operating Income
|
15m
USD
|
Other Expenses
|
-11.5m
USD
|
Net Income
|
3.6m
USD
|
MDP Profitability Score
Profitability Due Diligence
Medexus Pharmaceuticals Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Score
Medexus Pharmaceuticals Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
MDP Solvency Score
Solvency Due Diligence
Medexus Pharmaceuticals Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Score
Medexus Pharmaceuticals Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MDP Price Targets Summary
Medexus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
MDP
is 6.24 CAD
with a low forecast of 3.48 CAD and a high forecast of 10.5 CAD.
Dividends
Current shareholder yield for MDP is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MDP
stock under the Base Case scenario is
7.75
CAD.
Compared to the current market price of 2.69 CAD,
Medexus Pharmaceuticals Inc
is
Undervalued by 65%.